Analysis of prothrombin time prolongation in North American cefotetan clinical trials: questions and answers

Am J Surg. 1988 May 31;155(5A):44-6. doi: 10.1016/s0002-9610(88)80211-3.
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study

MeSH terms

  • Cefotetan
  • Cefoxitin / pharmacology
  • Ceftriaxone / pharmacology
  • Cephamycins / pharmacology
  • Cephamycins / therapeutic use*
  • Cephamycins / toxicity
  • Clinical Trials as Topic
  • Humans
  • Hypoprothrombinemias / chemically induced*
  • Moxalactam / pharmacology
  • Prothrombin Time*

Substances

  • Cephamycins
  • Cefotetan
  • Cefoxitin
  • Ceftriaxone
  • Moxalactam